Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0OR2 stock hub

LON/0OR2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0OR2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

265.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0OR2

In the news

Latest news · LON/0OR2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.1

P25 12.9P50 16.9P75 23.5

Trailing P/E12.6

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC7.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0OR2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

163

Groups with data

Currency

EUR

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	9,000
Employees Change	-619%
Employees Change Percent	-6.44
Enterprise value	EUR 995.3M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	FR0004170017
Last refreshed	2026-05-10
Market cap	EUR 265.9M
Price	EUR 30
Price currency	EUR
Rev Per Employee	96,134.82x
Sector	Healthcare
Sic	8300
Symbol	lon/0OR2
Website	https://www.lna-sante.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.92%
EV Earnings	47.25x
EV/EBIT	16.76x
EV/EBITDA	11.83x
EV/Sales	1.26x
Forward P/E	11.06x
P/E ratio	12.62x
P/S ratio	0.33x
PE Ratio10 Y	14.92x
PE Ratio3 Y	11.35x
PE Ratio5 Y	10.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.53%
EBITDA Margin	10.67%
Gross margin	7.53%
Gross Profit	EUR 60M
Gross Profit Growth	-74.09%
Gross Profit Growth3 Y	-33.98%
Gross Profit Growth5 Y	-21.73%
Net Income	EUR 21.1M
Net Income Growth	10.68%
Net Income Growth Q	35.75%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	0.42%
Net Income Growth5 Y	-0.04%
Pretax Margin	4.36%
Profit Margin	2.65%
Profit Per Employee	EUR 2,543
Profitable Years	14
ROIC	7.17
Roic5y	4.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.01%
Cagr1y	29.85%
Cagr3y	1.49%
Cagr5y	-7.61%
Div CAGR3	15.49%
Div CAGR5	6.74%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	13.15x
Revenue Growth Q	11.81x
Revenue Growth Quarters	12x
Revenue Growth Years	6x
Revenue Growth3 Y	6.2x
Revenue Growth5 Y	4.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Interest Coverage	2.38
WACC	6.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	10.73%
Dividend Growth Years	4%
Dividend per share	EUR 0.56
Dividend Years	10
Dividend Yield	1.92%
Ex Div Date	2025-07-08
Last Dividend	EUR 0.56
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	10.56%
1Y total return	29.83%
200-day SMA	26.08
3Y total return	4.54%
50-day SMA	27.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-32.67%
All Time High	68.51
All Time High Change	-56.21%
All Time High Date	2017-06-16
All Time Low	17.12
All Time Low Change	75.23%
All Time Low Date	2023-12-12
ATR	0.33
Beta	0.48
Ch YTD	22.45
High	30
High52	32.7
High52 Date	2025-08-07
High52ch	-8.26%
Low	29.6
Low52	22.8
Low52 Date	2025-10-28
Low52ch	31.58%
Ma50ch	10.3%
Price vs 200-day SMA	15.05%
RSI	74.94
RSI Monthly	58.11
RSI Weekly	67.92
Sharpe ratio	0.62x
Sortino ratio	1.16
Total Return	1.92%
Tr YTD	22.45
Tr1m	6.38%
Tr1w	4.17%
Tr3m	23.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 60M
Operating Income Growth	1.04
Operating Income Growth Q	1.99
Operating Income Growth3 Y	1.54
Operating Income Growth5 Y	8.01
Operating margin	7.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,065,933%
Shares Insiders	7.58%
Shares Institutions	15.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	172.3x
Ch10y	-1.64
Ch1m	6.38
Ch1w	4.17
Ch1y	26.58
Ch3m	23.97
Ch3y	-2.27
Ch5y	-38.08
Ch6m	25.26
Change	2.39%
Change From Open	1.35
Close	29.3
Days Gap	1.02
Depreciation Amortization	24,764,992.2
Dollar Volume	3,450
Earnings Date	2026-05-07
EBIT	EUR 60M
EBITDA	EUR 84.9M
F Score	1
Fiscal Year End	December
Founded	1,990
Income Tax	EUR 13.7M
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Lynch Fair Value	EUR 11.88
Lynch Upside	-60.4
Ma150	26.12
Ma150ch	14.84%
Ma20	28.81
Ma20ch	4.13%
Next Earnings Date	2026-09-16
Open	29.6
Payment Date	2025-07-10
Position In Range	100
Price Date	2026-05-08
Price EBITDA	EUR 3.13
Relative Volume	0.67x
Revenue	796,188,576x
Tax By Revenue	1.72x
Tax Rate	39.37%
Tr6m	25.26%
Volume	115

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0OR2 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$0.56 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.7%

4 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2025-07-08

Performance

LON/0OR2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0OR2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.9%

Share of float held by funds and institutions

Insider ownership

+7.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0OR2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

74.9

Above 70: short-term overbought

Price vs 200-day MA

+15.0%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0OR2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0OR2 stock rating?

lon/0OR2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0OR2 analysis?

The full report lives at /stocks/lon/0OR2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0OR2?

The latest report frames lon/0OR2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0OR2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.